skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: ClinicalKey remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Orthopedic Orientation
Orthopedic Orientation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Orthopedic Orientation

Faulhaber, Jo Ann ; Coleman, Jill A. ; Cardwell, Randall L.

AORN journal, 1987-10, Vol.46 (4), p.706,708,710,712,714-706,708,710,712,717 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
Orthopedic orientation. A guide for new nurses
Orthopedic orientation. A guide for new nurses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Orthopedic orientation. A guide for new nurses

Faulhaber, J A ; Coleman, J A ; Cardwell, R L

AORN journal, 1987-10, Vol.46 (4), p.706-717 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD
Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD

BURTSCHER, M ; HAIDER, T ; BERNARDI, L ; DOMEJ, W ; LINSER, T ; GATTERER, H ; FAULHABER, M ; POCECCO, E ; EHRENBURG, I ; TKATCHUK, E ; KOCH, R

Respiratory physiology & neurobiology, 2009, Vol.165 (1), p.97-103 [Periódico revisado por pares]

Amsterdam: Elsevier

Texto completo disponível

Citações Citado por
4
Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD
Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD

Burtscher, M ; Haider, T ; Domej, W ; Linser, T ; Gatterer, H ; Faulhaber, M ; Pocecco, E ; Ehrenburg, I ; Tkatchuk, E ; Koch, R ; Bernardi, L

Respiratory physiology & neurobiology, 2009-01, Vol.165 (1), p.97-103 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
5
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

Saad, Fred, Dr Prof ; Fizazi, Karim, Prof ; Jinga, Viorel, Prof ; Efstathiou, Eleni, MD ; Fong, Peter C, MD ; Hart, Lowell L, MD ; Jones, Robert, MD ; McDermott, Raymond, MD ; Wirth, Manfred, Prof ; Suzuki, Kazuhiro, Prof ; MacLean, David B, MD ; Wang, Ling, PhD ; Akaza, Hideyuki, Prof ; Nelson, Joel, Prof ; Scher, Howard I, Prof ; Dreicer, Robert, Prof ; Webb, Iain J, MD ; de Wit, Ronald, Prof

The lancet oncology, 2015-03, Vol.16 (3), p.338-348 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
FDG-PET imaging in hematological malignancies
FDG-PET imaging in hematological malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

FDG-PET imaging in hematological malignancies

Valls, L ; Badve, C ; Avril, S ; Herrmann, K ; Faulhaber, P ; O'Donnell, J ; Avril, N

Blood reviews, 2016-07, Vol.30 (4), p.317-331 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies
Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

Kindler, H. ; Harvey, R.D. ; Duska, L.R. ; Gandhi, L. ; Sullivan, R.J. ; Gastinne, T. ; Kwiatek, M. ; García-Sancho, A.M. ; Hadar, N. ; Kann, L. ; Faulhaber, N. ; Drescher, C.

European journal of cancer (1990), 2022-10, Vol.174, p.S31-S32 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
A0532 - Ongoing phase II study of EZH2 inhibitor CPI-0209 in patients with advanced solid tumors including metastatic castration-resistant prostate cancer (mCRPC) or hematologic malignancies
A0532 - Ongoing phase II study of EZH2 inhibitor CPI-0209 in patients with advanced solid tumors including metastatic castration-resistant prostate cancer (mCRPC) or hematologic malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A0532 - Ongoing phase II study of EZH2 inhibitor CPI-0209 in patients with advanced solid tumors including metastatic castration-resistant prostate cancer (mCRPC) or hematologic malignancies

Kwiatek, M. ; Gutierrez, M. ; Harvey, R.D. ; Sullivan, R.J. ; Walter, H.S. ; Faulhaber, N. ; Jauch-Lembach, J. ; Kann, L. ; Lakhani, N.J.

European urology, 2023-02, Vol.83, p.S758-S759 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
9
Ongoing phase II study of EZH2 inhibitor CPI-0209 in patients with advanced solid tumors including metastatic castration-resistant prostate cancer (mCRPC) or hematologic malignancies
Ongoing phase II study of EZH2 inhibitor CPI-0209 in patients with advanced solid tumors including metastatic castration-resistant prostate cancer (mCRPC) or hematologic malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ongoing phase II study of EZH2 inhibitor CPI-0209 in patients with advanced solid tumors including metastatic castration-resistant prostate cancer (mCRPC) or hematologic malignancies

Kwiatek, M. ; Gutierrez, M. ; Harvey, R.D. ; Sullivan, R.J. ; Walter, H.S. ; Faulhaber, N. ; Jauch-Lembach, J. ; Kann, L. ; Lakhani, N.J.

European urology, 2023-02, Vol.83, p.S758-S759 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.